Sign in here
A massive new study shows GLP-1 drugs like semaglutide don't just help with weight and blood sugar
Costantini, D
Proteccin renal con los agonistas del receptor del pptido similar al glucagn tipo 1 En los CVOT de los arGLP1 los resultados renales se preespecificaron como resultados secundarios clave en 4 estudios con liraglutida, semaglutida subcutnea, dulaglutida y efpeglenatida58,59,63,64, o se recogieron como parmetros de seguridad en otros estudios60
Anti-doping rules can apply even when a product is marketed as wellness support, injury recovery, or natural. When eligibility, testing, scholarships, or professional status are involved, the safest approach is to verify before use
Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-derived motor neurons from patients with ALS/FTD